Home > > Search result

Results: 2

Ebola outbreak in Guinea, 2021: Clinical care of patients with Ebola virus disease

Pare, Boyo C; Camara, Alseny M; Camara, Aminata; Kourouma, Moussa; Enogo, Koivogui; Camara, Mohammed S; Akilimali, Laurent; Sani, Sayadi; Barte de Sainte Fare, Eric; Lame, Papys; Mouly, Nicolas; Marta Lado Castro-Rial, Marta; Sivahera, Billy; Cherif, Mahamoud S; Beavogui, Abdoul H; Muamba, Dally; Tamba, Joachim B; Moumié, Barry; Kojan, Richard; Lang, Hans-Joerg.
S. Afr. j. infect. dis. (Online); 38 (1), 2023
Background: Experience from the Zaire Ebolavirus epidemic in the eastern Democratic Republic of the Congo (2018–2020) demonstrates that early initiation of essential critical care and administration of Zaire Ebolavirus specific monoclonal antibodies may be associated with improved outcomes among patien...
Hemorrhagic Fever, Ebola, Antibodies, Monoclonal, Ebola Vaccines, Lassa Fever, Critical Care, Critical Pathways
Fulltext

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Corey, lawrence; Gilbert, peter B; Juraska, michal; Montefiori, david C; Morris, lynn.
N. Engl. j. med; 384 (11), 2021
BACKGROUND—Whether a broadly neutralizing antibody (bnAb) can be used to prevent human immunodeficiency virus type 1 (HIV-1) acquisition is unclear. METHODS—We enrolled at-risk cisgender men and transgender persons in the Americas and Europe in the HVTN 704/HPTN 085 trial and at-risk women in sub-Sah...
Africa South of the Sahara, Antibodies, Monoclonal, Broadly Neutralizing Antibodies, Double-Blind Method, HIV Antibodies, HIV Infections, Mozambique
Fulltext